Enhancing adoptive T cell therapy with synergistic host immune engagement promotes long-term protection against solid tumors
K. Adu-Berchie, J. M. Brockman, Y. Liu, D. K. Y. Zhang, A. J. Najibi, A. Stafford, M. C. Sobral, Y. Binenbaum, M. O. Dellacherie, D. J. Mooney
This paper presents a biomaterial platform that enhances adoptive T cell therapy by engaging the host immune system, leading to better tumor control and long-term protection against solid tumors.
bioRxiv · Sep 10, 2022 · PreprintImmunology